$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

$fcuv Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000168316824001995 Filed on April 01, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$19.75K	$282.3K	$1.052M
YoY Change	-90.83%	296.77%	197.55%
Cost Of Revenue	$31.83K	$427.0K	$958.4K
YoY Change	-78.67%	385.8%	189.64%
Gross Profit	-$12.08K	-$144.7K	$93.79K
YoY Change	-118.27%	764.28%	312.81%
Gross Profit Margin	-61.16%	-51.24%	8.91%
Selling, General & Admin	$661.1K	$1.014M	$3.670M
YoY Change	55.69%	19.93%	65.57%
% of Gross Profit			3912.76%
Research & Development	$296.2K	$461.5K	$1.387M
YoY Change	-13.63%	132.87%	30.78%
% of Gross Profit			1478.63%
Depreciation & Amortization	$32.02K	$40.81K	$168.0K
YoY Change	-24.8%	-3.66%	1.03%
% of Gross Profit			179.1%
Operating Expenses	$1.367M	$1.475M	$5.057M
YoY Change	20.17%	35.89%	-3.29%
Operating Profit	-$1.379M	-$1.620M	-$4.963M
YoY Change	28.71%	46.95%	-4.66%
Interest Expense	-$73.68K	-$29.94K	$6.040K
YoY Change	-726.0%	-3094.0%	-134.87%
% of Operating Profit
Other Income/Expense, Net	$14.03K	$94.04K	$238.6K
YoY Change	-73.69%	-184.14%	-14.38%
Pretax Income	-$1.365M	-$1.618M	-$4.718M
YoY Change	34.08%	53.38%	-4.24%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$1.365M	-$1.618M	-$4.718M
YoY Change	34.07%	53.38%	-4.24%
Net Earnings / Revenue	-6910.88%	-572.96%	-448.41%
Basic Earnings Per Share	-$0.02		-$0.08
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.08
COMMON SHARES
Basic Shares Outstanding	64.77M shares	64.82M shares	60.31M shares
Diluted Shares Outstanding	64.84M shares		60.31M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.64K	$465.0K	$465.0K
YoY Change	-97.14%	-89.55%	-89.55%
Cash & Equivalents	$13.06K	$428.3K	$428.3K
Short-Term Investments	$27.58K	$36.74K	$36.74K
Other Short-Term Assets	$97.97K	$96.30K	$96.30K
YoY Change	-47.67%	-32.35%	-32.35%
Inventory	$495.9K	$282.1K	$282.1K
Prepaid Expenses	$97.97K	$96.30K
Receivables	$19.78K	$164.4K	$164.4K
Other Receivables	$0.00	$20.52K	$20.52K
Total Short-Term Assets	$654.3K	$1.028M	$1.028M
YoY Change	-63.57%	-78.61%	-78.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.022M	$4.282M	$4.282M
YoY Change	-3.3%	1.26%	-4.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$25.71K	$24.14K	$24.14K
YoY Change	9.17%	-27.42%	-27.42%
Total Long-Term Assets	$4.201M	$4.306M	$4.306M
YoY Change	-4.94%	-4.64%	-4.64%
TOTAL ASSETS
Total Short-Term Assets	$654.3K	$1.028M	$1.028M
Total Long-Term Assets	$4.201M	$4.306M	$4.306M
Total Assets	$4.855M	$5.334M	$5.334M
YoY Change	-21.88%	-42.79%	-42.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.061M	$482.5K	$482.5K
YoY Change	247.48%	80.25%	80.25%
Accrued Expenses	$99.57K	$90.17K	$90.17K
YoY Change	22.62%	-20.25%	-20.25%
Deferred Revenue
YoY Change
Short-Term Debt	$225.0K	$1.000M	$1.000M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.664M	$1.658M	$1.658M
YoY Change	747.81%	19.49%	19.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$130.9K	$130.9K
YoY Change	-100.0%	960.8%	-26.61%
Total Long-Term Liabilities	$31.80K	$130.9K	$130.9K
YoY Change	-77.9%	-26.61%	-26.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.664M	$1.658M	$1.658M
Total Long-Term Liabilities	$31.80K	$130.9K	$130.9K
Total Liabilities	$3.696M	$1.789M	$1.789M
YoY Change	541.53%	14.24%	14.24%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.26M	-$22.58M
YoY Change	26.34%	26.41%
Common Stock	$64.87K	$64.77K
YoY Change	0.15%	48.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.160M	$3.546M	$3.546M
YoY Change
Total Liabilities & Shareholders Equity	$4.855M	$5.334M	$5.334M
YoY Change	-21.88%	-42.79%	-42.79%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.365M	-$1.618M	-$4.718M
YoY Change	34.07%	53.38%	-4.24%
Depreciation, Depletion And Amortization	$32.02K	$40.81K	$168.0K
YoY Change	-24.8%	-3.66%	1.03%
Cash From Operating Activities	-$829.9K	-$925.2K	-$3.529M
YoY Change	8.03%	76.97%	19.3%
INVESTING ACTIVITIES
Capital Expenditures	$4.700K	$330.00	$20.62K
YoY Change	-35.44%	-89.0%	-51.12%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$74.77K
YoY Change	-100.0%	-100.0%	-144.22%
Cash From Investing Activities	-$4.700K	-$320.00	$54.15K
YoY Change	-77.54%	-99.05%	-125.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$1.434M
YoY Change			-243.41%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	776.0K	-48.36K	-434.1K
YoY Change	-284.46%	-95.83%	-62.53%
NET CHANGE
Cash From Operating Activities	-829.9K	-925.2K	-3.529M
Cash From Investing Activities	-4.700K	-320.0	54.15K
Cash From Financing Activities	776.0K	-48.36K	-434.1K
Net Change In Cash	-58.56K	-973.9K	-3.909M
YoY Change	-95.16%	-43.21%	-9.84%
FREE CASH FLOW
Cash From Operating Activities	-$829.9K	-$925.2K	-$3.529M
Capital Expenditures	$4.700K	$330.00	$20.62K
Free Cash Flow	-$834.6K	-$925.5K	-$3.549M
YoY Change	7.62%	76.02%	18.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001590418
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	FCUV	Stock Issued During Period Value Issued For Prior Services StockIssuedDuringPeriodValueIssuedForPriorServices		usd
CY2022	FCUV	Shares Issued For Cashless Exercise Of Warrants Value SharesIssuedForCashlessExerciseOfWarrantsValue		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount		usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	47304201	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64771817	shares
CY2023	dei	Auditor Firm AuditorFirmId	572
CY2022	dei	Auditor Firm AuditorFirmId	6906
CY2023	dei	Auditor Name AuditorName	Weinberg & Company, P.A.
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, CA.
CY2022	dei	Auditor Name AuditorName	Reliant CPA PC
CY2022	dei	Auditor Location AuditorLocation	Newport Beach, CA
CY2023Q4	us-gaap	Cash Cash	428254	usd
CY2022Q4	us-gaap	Cash Cash	4343426	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	164398	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78313	usd
CY2023Q4	FCUV	Accounts Receivable Related Party Current AccountsReceivableRelatedPartyCurrent	0	usd
CY2022Q4	FCUV	Accounts Receivable Related Party Current AccountsReceivableRelatedPartyCurrent	34507	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	282071	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	20519	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	96301	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	142342	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	36735	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	105470	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1028278	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4807830	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4080663	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	201048	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	24135	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	33264	usd
CY2023Q4	us-gaap	Assets Assets	5334124	usd
CY2022Q4	us-gaap	Assets Assets	9323060	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	482523	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	267685	usd
CY2023Q4	FCUV	Treasurys Stock Payable TreasurysStockPayable	0	usd
CY2022Q4	FCUV	Treasurys Stock Payable TreasurysStockPayable	1000000	usd
CY2023Q4	FCUV	Related Party Loan RelatedPartyLoan	1000000	usd
CY2022Q4	FCUV	Related Party Loan RelatedPartyLoan	0	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	84951	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6496	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	90172	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1657646	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1387239	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	118517	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	130852	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	178287	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1788498	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1565526	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64771817	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64771817	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65296383	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65296383	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	64771	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	65297	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1163040	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	600000	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	434048	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26436161	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27514733	usd
CY2023Q4	FCUV	Shares To Be Issued Common Shares SharesToBeIssuedCommonShares	41643	shares
CY2022Q4	FCUV	Shares To Be Issued Common Shares SharesToBeIssuedCommonShares	16875	shares
CY2023Q4	FCUV	Shares To Be Issued Common Shares Value SharesToBeIssuedCommonSharesValue	74476	usd
CY2022Q4	FCUV	Shares To Be Issued Common Shares Value SharesToBeIssuedCommonSharesValue	48075	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22582170	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17864028	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13564	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6543	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3545626	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5334124	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9323060	usd
CY2023	us-gaap	Revenues Revenues	1052198	usd
CY2022	us-gaap	Revenues Revenues	353619	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	958413	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	330899	usd
CY2023	us-gaap	Gross Profit GrossProfit	93785	usd
CY2022	us-gaap	Gross Profit GrossProfit	22720	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	515490	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	431813	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	469048	usd
CY2023	FCUV	Amendment Stock Purchase Agreement Treasury Stock AmendmentStockPurchaseAgreementTreasuryStock	35000	usd
CY2023	us-gaap	Selling Expense SellingExpense	140994	usd
CY2022	us-gaap	Selling Expense SellingExpense	142372	usd
CY2023	us-gaap	Officers Compensation OfficersCompensation	1082775	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	1055133	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1386810	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1060385	usd
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	705234	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	896385	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1740779	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2074091	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	5056592	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5228366	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4962807	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5205646	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	158547	usd
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	8033	usd
CY2022	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-42395	usd
CY2023	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-2002	usd
CY2022	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-21205	usd
CY2023	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	160910	usd
CY2022	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	166288	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	77718	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13587	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	244665	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	278709	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4718142	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	7021	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	6539	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4725163	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4933476	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60314871	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60314871	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65119620	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65119620	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	849043	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	711975	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	8000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6539	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4718142	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	26631	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	136337	usd
CY2023	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	0	usd
CY2022	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-27199	usd
CY2023	us-gaap	Depreciation Depreciation	167983	usd
CY2022	us-gaap	Depreciation Depreciation	166266	usd
CY2023	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	8033	usd
CY2022	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-42395	usd
CY2023	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-2002	usd
CY2022	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-21205	usd
CY2023	FCUV	Share Based Compensation Shares Value ShareBasedCompensationSharesValue	431813	usd
CY2022	FCUV	Share Based Compensation Shares Value ShareBasedCompensationSharesValue	719975	usd
CY2023	FCUV	Share Based Compensation Options Value ShareBasedCompensationOptionsValue	515490	usd
CY2022	FCUV	Share Based Compensation Options Value ShareBasedCompensationOptionsValue	849043	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	112716	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37335	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-34507	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	19331	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	178299	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	53684	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	20519	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-13057	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-45602	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-158474	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-8336	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-4035	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	325329	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	139754	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	215531	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-21722	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	78455	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-17135	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-342732	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-117245	usd
CY2023	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	0	usd
CY2022	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	12064	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3528762	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2957983	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20620	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42187	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	43644	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	768949	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	118410	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	599879	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	54146	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-211257	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1000000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2023	FCUV	Forgiveness Of Debt ForgivenessOfDebt	-0	usd
CY2022	FCUV	Forgiveness Of Debt ForgivenessOfDebt	158547	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1434048	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-434048	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1158547	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6508	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7452	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3915172	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4335239	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4343426	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8678665	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	428254	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4343426	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	13142	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	12164	usd
CY2023	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	273041	usd
CY2022	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	0	usd
CY2023	FCUV	Cashless Exercise Of Options CashlessExerciseOfOptions	41401	usd
CY2022	FCUV	Cashless Exercise Of Options CashlessExerciseOfOptions	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_z4XrJuXDeIU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_zS5d6TM3z2O4">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include the useful lives of property and equipment, allowance for doubtful accounts, inventory reserves, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and the valuation allowance on deferred tax assets. The Company regularly evaluates its estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
CY2023	us-gaap	Revenues Revenues	1052198	usd
CY2022	us-gaap	Revenues Revenues	353619	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3120763	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	249603	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	222972	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zVF7vbVQ6C23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_zwMOO8ub95Wl">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by investing its cash with high credit quality financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Stock Dividends Shares StockDividendsShares	21592164	shares
CY2023Q2	us-gaap	Stock Dividends Shares StockDividendsShares	21592164	shares
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	36735	usd
CY2022Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	105470	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	513874	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	458424	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4718142	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22582170	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17864028	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3528762	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2957983	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	464989	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1051	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	3767	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	281020	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	100005	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	282071	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4922318	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4902400	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	841655	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	673770	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4080663	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2023	us-gaap	Depreciation Depreciation	167983	usd
CY2022	us-gaap	Depreciation Depreciation	166266	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	143097	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	209738	usd
CY2023Q4	FCUV	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	273041	usd
CY2022Q4	FCUV	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	353074	usd
CY2023Q4	FCUV	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	71993	usd
CY2022Q4	FCUV	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	99738	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	201048	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	90172	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	118517	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2022	FCUV	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P2Y2M1D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	104767	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	114641	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8480	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	227888	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19199	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	208689	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	FCUV	Share Based Compensation Arrangement By Share Based Payment Award Amortized Unvested Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardAmortizedUnvestedNumberOfShares	153000	shares
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	986655	usd
CY2023	FCUV	Revenue Related Party RevenueRelatedParty	65543	usd
CY2023	us-gaap	Revenues Revenues	1052198	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	958413	usd
CY2023	us-gaap	Gross Profit GrossProfit	93785	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	5056592	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4962807	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	244665	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4718142	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	303837	usd
CY2022	FCUV	Revenue Related Party RevenueRelatedParty	49782	usd
CY2022	us-gaap	Revenues Revenues	353619	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	330899	usd
CY2022	us-gaap	Gross Profit GrossProfit	22720	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5228366	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5205646	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	278709	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.25	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-991000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1034596	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-313000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-435516	usd
CY2023	FCUV	Income Tax Reconciliation Foreign Income Tax IncomeTaxReconciliationForeignIncomeTax	-46000	usd
CY2022	FCUV	Income Tax Reconciliation Foreign Income Tax IncomeTaxReconciliationForeignIncomeTax	-129904	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-86	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1350000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1600102	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	6612282	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	5261884	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	43872	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	43786	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6656154	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5305670	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6656154	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5305670	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1350484	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	4354568	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	17195453	usd
CY2023	FCUV	Future Taxable Income FutureTaxableIncome	3540588	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-001995-index-headers.html	Edgar Link	pending
0001683168-24-001995-index.html	Edgar Link	pending
0001683168-24-001995.txt	Edgar Link	pending
0001683168-24-001995-xbrl.zip	Edgar Link	pending
fcuv-20231231.xsd	Edgar Link	pending
fcuv-20231231_cal.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
focus_ex1015.htm	Edgar Link	pending
focus_ex2101.htm	Edgar Link	pending
focus_ex3101.htm	Edgar Link	pending
focus_ex3102.htm	Edgar Link	pending
focus_ex3201.htm	Edgar Link	pending
focus_ex3202.htm	Edgar Link	pending
focus_ex97.htm	Edgar Link	pending
focus_i10k-123123.htm	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
image_023.jpg	Edgar Link	pending
image_024.jpg	Edgar Link	pending
image_025.jpg	Edgar Link	pending
image_026.jpg	Edgar Link	pending
image_027.jpg	Edgar Link	pending
image_028.jpg	Edgar Link	pending
image_029.jpg	Edgar Link	pending
image_030.jpg	Edgar Link	pending
image_031.jpg	Edgar Link	pending
image_032.jpg	Edgar Link	pending
image_033.jpg	Edgar Link	pending
image_034.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
fcuv-20231231_lab.xml	Edgar Link	unprocessable
fcuv-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
focus_i10k-123123_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fcuv-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

2024 Q2 Form 10-K Financial Statement

#000168316824001995 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV FOCUS UNIVERSAL INC. Stock $fcuv

2024 Q2 Form 10-K Financial Statement

#000168316824001995 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv